[VRDN] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
26-Oct-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 26.65%
YoY- 41.66%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 718 462 756 889 874 818 659 5.88%
PBT -7,312 -6,980 -5,570 -1,839 -2,507 -2,758 -2,980 82.01%
Tax 102 30 -71 0 0 0 -47 -
NP -7,312 -6,980 -5,570 -1,839 -2,507 -2,758 -2,980 82.01%
Tax Rate - - - - - - - -
Total Cost 8,030 7,442 6,326 2,728 3,381 3,576 3,639 69.57%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -1,018.38 -1,510.82 -736.77 -206.86 -286.84 -337.16 -452.20 71.89%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -5.12 -9.06 -7.23 -2.56 -3.50 -3.85 -4.19 14.31%
EPS Diluted -5.12 -9.06 -7.23 -2.56 -3.50 -3.85 -4.19 14.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.